Camp4 Therapeutics (CAMP) Other Accumulated Expenses (2023 - 2025)
Camp4 Therapeutics (CAMP) posted Other Accumulated Expenses of $27000.0 for Q4 2025, down 84.66% sequentially from $176000.0 in Q4 2024, and down 84.66% YoY from $176000.0 in Q4 2024.
Analysis
Camp4 Therapeutics (CAMP) Other Accumulated Expenses (2023 - 2025) Analysis & Trends
Camp4 Therapeutics has reported Other Accumulated Expenses for 3 years, with the latest figure at $27000.0 in Q4 2025.
- Quarterly Other Accumulated Expenses fell 84.66% year-over-year to $27000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $27000.0 (down 84.66% YoY) and the FY2025 annual result came in at $27000.0, down 84.66% from the prior year.
- Other Accumulated Expenses fell to $27000.0 in Q4 2025 per CAMP's latest filing, from $176000.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $369000.0 in Q3 2024 and troughed at $27000.0 in Q4 2025.
- A 3-year average of $215250.0 and a median of $232500.0 in 2023 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses plunged 39.1% in 2024, then sank 84.66% in 2025.
- Over 3 years, Other Accumulated Expenses stood at $289000.0 in 2023, then slumped by 39.1% to $176000.0 in 2024, then tumbled by 84.66% to $27000.0 in 2025.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $27000.0, $176000.0, and $369000.0 for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Camp4 Therapeutics | 260.10 Mn | 260.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 176,000.00 |
| Sep 30, 2024 | 369,000.00 |
| Dec 31, 2023 | 289,000.00 |